Clinical Trial Update: Combined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line Treatment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial exploring the combined use of natural killer cell therapy with doublet chemotherapy as first-line treatment for advanced non-small cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Doublet chemotherapy (doublet chemotherapy)
• Natural Killer cell therapy (natural killer cell therapy)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN